[1]
A. Q. W. Muhammed and H. R. Hassan, “Evaluation the Effects of Complement Terminal Component (C5b-9) on Immunothrombosis in Severe and Critical COVID-19 Infections Compared to Mild Cases”, sjomr, vol. 6, no. 24, Dec. 2022.